Oruka Therapeutics, Inc. (ORKA)
64.59
+0.52
(+0.81%)
USD |
NASDAQ |
May 08, 16:00
64.57
-0.02
(-0.03%)
After-Hours: 20:00
Oruka Therapeutics Total Liabilities (Quarterly) : 16.69M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | 10.33M |
| MapLight Therapeutics, Inc. | 21.14M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 91.99M |
| Insight Molecular Diagnostics, Inc. | 57.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 488.62M |
| Shareholders Equity (Quarterly) | 471.93M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 22.37 |
| Net Debt Paydown Yield | -0.01% |